Long-term hepatitis B virus (HBV) response to Lamivudine-containing highly active antiretroviral therapy in HIV-HBV co-infected patients in Thailand
Background: Approximately 4 million of people are co-infected with HIV and Hepatitis B virus (HBV). In resource-limited settings, the majority of HIV-infected patients initiate first-line highly active antiretroviral therapy containing lamivudine (3TC-containing-HAART) and long-term virological resp...
Saved in:
相似書籍
-
Long-term hepatitis B virus (HBV) response to Lamivudine-containing highly active antiretroviral therapy in HIV-HBV co-infected patients in Thailand
由: Khamduang W., et al.
出版: (2014) -
Analysis of residual perinatal transmission of hepatitis B virus (HBV) and of genetic variants in human immunodeficiency virus and HBV co-infected women and their offspring
由: Woottichai Khamduang, et al.
出版: (2018) -
Analysis of residual perinatal transmission of hepatitis B virus (HBV) and of genetic variants in human immunodeficiency virus and HBV co-infected women and their offspring
由: Woottichai Khamduang, et al.
出版: (2018) -
Analysis of residual perinatal transmission of hepatitis B virus (HBV) and of genetic variants in human immunodeficiency virus and HBV co-infected women and their offspring
由: Khamduang W., et al.
出版: (2014) -
Single-virion sequencing of lamivudine-treated HBV populations reveal population evolution dynamics and demographic history
由: Zhu, Y.O, et al.
出版: (2020)